Analysts New Coverage

Rev Group Inc (REVG) Now Covered by Analysts at Wells Fargo & Co

Rev Group Inc (REVG) Now Covered by Analysts at Wells Fargo & Co

Wells Fargo & Co assumed coverage on shares of Rev Group Inc (NASDAQ:REVG) in a research note issued to investors on Tuesday. The firm set an “outperform” rating on the stock. A number of other analysts also recently weighed in on the company. Morgan Stanley started coverage on Rev Group in a research note on […]
Rev Group Inc (REVG) Now Covered by Analysts at Stifel Nicolaus

Rev Group Inc (REVG) Now Covered by Analysts at Stifel Nicolaus

Equities research analysts at Stifel Nicolaus initiated coverage on shares of Rev Group Inc (NASDAQ:REVG) in a research note issued on Tuesday. The firm set a “buy” rating and a $33.00 price target on the stock. Stifel Nicolaus’ target price indicates a potential upside of 18.53% from the stock’s current price. Rev Group (NASDAQ:REVG) traded […]
Rev Group Inc (REVG) Now Covered by Analysts at Morgan Stanley

Rev Group Inc (REVG) Now Covered by Analysts at Morgan Stanley

Investment analysts at Morgan Stanley started coverage on shares of Rev Group Inc (NASDAQ:REVG) in a report released on Tuesday. The brokerage set an “equal weight” rating and a $30.00 price target on the stock. Morgan Stanley’s target price would indicate a potential upside of 7.76% from the stock’s current price. Separately, Stifel Nicolaus assumed […]
C4X Discovery Holdings PLC (C4XD) Coverage Initiated at Panmure Gordon

C4X Discovery Holdings PLC (C4XD) Coverage Initiated at Panmure Gordon

Analysts at Panmure Gordon initiated coverage on shares of C4X Discovery Holdings PLC (LON:C4XD) in a research report issued on Tuesday. The firm set a “buy” rating and a GBX 129 ($1.59) price target on the stock. Panmure Gordon’s price target would indicate a potential upside of 40.98% from the stock’s current price. C4X Discovery […]
Jounce Therapeutics Inc (JNCE) Research Coverage Started at Robert W. Baird

Jounce Therapeutics Inc (JNCE) Research Coverage Started at Robert W. Baird

Analysts at Robert W. Baird assumed coverage on shares of Jounce Therapeutics Inc (NASDAQ:JNCE) in a note issued to investors on Tuesday. The brokerage set an “outperform” rating and a $30.00 price target on the stock. Robert W. Baird’s price objective would indicate a potential upside of 17.28% from the company’s current price. Separately, Wells […]
Jounce Therapeutics Inc (JNCE) Research Coverage Started at Wells Fargo & Co

Jounce Therapeutics Inc (JNCE) Research Coverage Started at Wells Fargo & Co

Equities research analysts at Wells Fargo & Co started coverage on shares of Jounce Therapeutics Inc (NASDAQ:JNCE) in a research report issued on Tuesday. The brokerage set an “outperform” rating on the stock. The analysts noted that the move was a valuation call. Shares of Jounce Therapeutics (NASDAQ:JNCE) traded up 5.75% during midday trading on […]
Jounce Therapeutics Inc (JNCE) Now Covered by JPMorgan Chase & Co.

Jounce Therapeutics Inc (JNCE) Now Covered by JPMorgan Chase & Co.

Analysts at JPMorgan Chase & Co. assumed coverage on shares of Jounce Therapeutics Inc (NASDAQ:JNCE) in a research report issued on Tuesday. The brokerage set an “overweight” rating and a $28.00 price target on the stock. JPMorgan Chase & Co.’s target price would suggest a potential upside of 9.46% from the stock’s previous close. Several […]
JPMorgan Chase & Co. Begins Coverage on Jagged Peak Energy Inc (JAG)

JPMorgan Chase & Co. Begins Coverage on Jagged Peak Energy Inc (JAG)

JPMorgan Chase & Co. assumed coverage on shares of Jagged Peak Energy Inc (NYSE:JAG) in a report released on Tuesday. The firm set an “overweight” rating and a $23.00 price target on the mining company’s stock. JPMorgan Chase & Co.’s target price suggests a potential upside of 86.84% from the company’s current price. Separately, Susquehanna […]
Rev Group Inc (REVG) Receives New Coverage from Analysts at Goldman Sachs Group Inc

Rev Group Inc (REVG) Receives New Coverage from Analysts at Goldman Sachs Group Inc

Analysts at Goldman Sachs Group Inc assumed coverage on shares of Rev Group Inc (NASDAQ:REVG) in a report released on Tuesday. The brokerage set a “neutral” rating on the stock. A number of other research firms also recently weighed in on REVG. Robert W. Baird began coverage on shares of Rev Group in a research […]
Jagged Peak Energy Inc (JAG) Receives New Coverage from Analysts at Wells Fargo & Co

Jagged Peak Energy Inc (JAG) Receives New Coverage from Analysts at Wells Fargo & Co

Wells Fargo & Co assumed coverage on shares of Jagged Peak Energy Inc (NYSE:JAG) in a note issued to investors on Tuesday. The brokerage set an “outperform” rating and a $23.00 price target on the mining company’s stock. Wells Fargo & Co’s price target points to a potential upside of 86.84% from the company’s previous […]
ViaSat, Inc. (VSAT) Research Coverage Started at Barclays PLC

ViaSat, Inc. (VSAT) Research Coverage Started at Barclays PLC

Barclays PLC started coverage on shares of ViaSat, Inc. (NASDAQ:VSAT) in a report issued on Tuesday. The firm set an “equal weight” rating and a $75.00 price target on the stock. Barclays PLC’s price target would indicate a potential upside of 17.85% from the company’s current price. Other analysts have also issued reports about the […]
Jagged Peak Energy Inc (JAG) Earns Overweight Rating from Analysts at KeyCorp

Jagged Peak Energy Inc (JAG) Earns Overweight Rating from Analysts at KeyCorp

Analysts at KeyCorp started coverage on shares of Jagged Peak Energy Inc (NYSE:JAG) in a report issued on Tuesday. The firm set an “overweight” rating and a $18.00 price target on the mining company’s stock. KeyCorp’s target price would indicate a potential upside of 46.22% from the stock’s current price. The analysts noted that the […]
SemGroup Corp (SEMG) Coverage Initiated at Barclays PLC

SemGroup Corp (SEMG) Coverage Initiated at Barclays PLC

Analysts at Barclays PLC started coverage on shares of SemGroup Corp (NASDAQ:SEMG) in a research report issued to clients and investors on Tuesday. The brokerage set an “equal weight” rating and a $43.00 price target on the stock. Barclays PLC’s price objective indicates a potential upside of 29.91% from the stock’s current price. A number […]
Jeld-Wen Holding Inc (JELD) Coverage Initiated by Analysts at Wells Fargo & Co

Jeld-Wen Holding Inc (JELD) Coverage Initiated by Analysts at Wells Fargo & Co

Equities researchers at Wells Fargo & Co began coverage on shares of Jeld-Wen Holding Inc (NYSE:JELD) in a report released on Tuesday. The firm set an “outperform” rating on the stock. Separately, Wedbush assumed coverage on Jeld-Wen Holding in a research report on Friday, February 3rd. They set an “outperform” rating and a $31.00 target […]
Jeld-Wen Holding Inc (JELD) Coverage Initiated by Analysts at JPMorgan Chase & Co.

Jeld-Wen Holding Inc (JELD) Coverage Initiated by Analysts at JPMorgan Chase & Co.

Analysts at JPMorgan Chase & Co. started coverage on shares of Jeld-Wen Holding Inc (NYSE:JELD) in a research report issued to clients and investors on Tuesday. The firm set a “neutral” rating and a $32.00 price target on the stock. JPMorgan Chase & Co.’s target price suggests a potential downside of 1.75% from the company’s […]
Barclays PLC Initiates Coverage on Jeld-Wen Holding Inc (JELD)

Barclays PLC Initiates Coverage on Jeld-Wen Holding Inc (JELD)

Barclays PLC started coverage on shares of Jeld-Wen Holding Inc (NYSE:JELD) in a report issued on Tuesday. The brokerage set an “overweight” rating and a $35.00 price target on the stock. Barclays PLC’s price target would suggest a potential upside of 7.46% from the stock’s current price. A number of other brokerages also recently issued […]
Rev Group Inc (REVG) Research Coverage Started at Robert W. Baird

Rev Group Inc (REVG) Research Coverage Started at Robert W. Baird

Stock analysts at Robert W. Baird initiated coverage on shares of Rev Group Inc (NASDAQ:REVG) in a note issued to investors on Tuesday. The firm set an “outperform” rating and a $31.00 price target on the stock. Robert W. Baird’s target price would indicate a potential upside of 11.35% from the company’s previous close. Several […]
Jeld-Wen Holding Inc (JELD) Research Coverage Started at Robert W. Baird

Jeld-Wen Holding Inc (JELD) Research Coverage Started at Robert W. Baird

Analysts at Robert W. Baird initiated coverage on shares of Jeld-Wen Holding Inc (NYSE:JELD) in a report released on Tuesday. The brokerage set an “outperform” rating and a $34.00 price target on the stock. Robert W. Baird’s target price would indicate a potential upside of 4.39% from the company’s previous close. A number of other […]
AnaptysBio Inc (ANAB) Coverage Initiated at JMP Securities

AnaptysBio Inc (ANAB) Coverage Initiated at JMP Securities

JMP Securities began coverage on shares of AnaptysBio Inc (NASDAQ:ANAB) in a note issued to investors on Tuesday. The brokerage set an “outperform” rating on the stock. Shares of AnaptysBio (NASDAQ:ANAB) traded up 0.51% during trading on Tuesday, hitting $27.74. 65,480 shares of the stock traded hands. AnaptysBio has a 1-year low of $15.17 and […]
Obseva SA (OBSV) Coverage Initiated by Analysts at Jefferies Group LLC

Obseva SA (OBSV) Coverage Initiated by Analysts at Jefferies Group LLC

Jefferies Group LLC started coverage on shares of Obseva SA (NASDAQ:OBSV) in a report released on Tuesday. The firm set a “buy” rating and a $21.00 price target on the stock. Jefferies Group LLC’s price objective suggests a potential upside of 87.50% from the stock’s previous close. Shares of Obseva SA (NASDAQ:OBSV) traded down 0.3550% […]
ChemoCentryx Inc (CCXI) Coverage Initiated by Analysts at JMP Securities

ChemoCentryx Inc (CCXI) Coverage Initiated by Analysts at JMP Securities

Equities researchers at JMP Securities initiated coverage on shares of ChemoCentryx Inc (NASDAQ:CCXI) in a research report issued on Tuesday. The brokerage set an “outperform” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research upgraded ChemoCentryx from a “hold” rating to a “buy” rating and set a $9.00 target price for the company in […]
Leerink Swann Begins Coverage on Obseva SA (OBSV)

Leerink Swann Begins Coverage on Obseva SA (OBSV)

Investment analysts at Leerink Swann started coverage on shares of Obseva SA (NASDAQ:OBSV) in a report released on Tuesday. The firm set an “outperform” rating and a $21.00 price target on the stock. Leerink Swann’s price objective indicates a potential upside of 87.50% from the stock’s current price. Several other analysts also recently commented on […]
SunTrust Banks, Inc. Begins Coverage on Jeld-Wen Holding Inc (JELD)

SunTrust Banks, Inc. Begins Coverage on Jeld-Wen Holding Inc (JELD)

Stock analysts at SunTrust Banks, Inc. began coverage on shares of Jeld-Wen Holding Inc (NYSE:JELD) in a research note issued to investors on Tuesday. The firm set a “hold” rating and a $31.00 price target on the stock. SunTrust Banks, Inc.’s price target indicates a potential downside of 4.82% from the company’s previous close. Several […]
Horizon Global Corp (HZN) Coverage Initiated at Wells Fargo & Co

Horizon Global Corp (HZN) Coverage Initiated at Wells Fargo & Co

Wells Fargo & Co initiated coverage on shares of Horizon Global Corp (NYSE:HZN) in a note issued to investors on Tuesday. The brokerage set a “market perform” rating on the stock. Separately, Zacks Investment Research lowered shares of Horizon Global Corp from a “hold” rating to a “sell” rating in a research note on Wednesday, […]
Jounce Therapeutics Inc (JNCE) Research Coverage Started at Cowen and Company

Jounce Therapeutics Inc (JNCE) Research Coverage Started at Cowen and Company

Cowen and Company started coverage on shares of Jounce Therapeutics Inc (NASDAQ:JNCE) in a research note issued on Tuesday. The firm set an “outperform” rating on the stock. Other equities analysts also recently issued reports about the stock. Robert W. Baird initiated coverage on shares of Jounce Therapeutics in a report on Tuesday, February 21st. […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.